Bristol-Myers Squibb
BMY
BMY
1,312 hedge funds and large institutions have $61.7B invested in Bristol-Myers Squibb in 2013 Q4 according to their latest regulatory filings, with 179 funds opening new positions, 389 increasing their positions, 567 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.16% more ownership
Funds ownership: 69.3% → 70.46% (+1.2%)
11% less call options, than puts
Call options by funds: $776M | Put options by funds: $870M
31% less repeat investments, than reductions
Existing positions increased: 389 | Existing positions reduced: 567
Holders
1,312
Holding in Top 10
65
Calls
$776M
Puts
$870M
Top Buyers
| 1 | +$766M | |
| 2 | +$454M | |
| 3 | +$400M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$328M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$326M |
Top Sellers
| 1 | -$839M | |
| 2 | -$425M | |
| 3 | -$293M | |
| 4 |
Renaissance Technologies
New York
|
-$228M |
| 5 |
Bank of New York Mellon
New York
|
-$203M |